Background: Previous studies have reported that gut microbiota is associated with an
increased risk of chronic kidney disease (CKD) progression. However, whether gut …

Background: Targeting the gut microbiota may become a new therapeutic to prevent and
delay the progression of chronic kidney disease (CKD). Nonetheless, the causal relationship …

Background The association of gut microbiota (GM) and chronic kidney disease (CKD), and
the relevancy of GM and chronic systemic inflammation in CKD, were revealed on the basis …

Background: The microbiota composition is now considered as one of the main modifiable
risk factors for health. No controlled study has been performed on the association between …

Alterations to the gut microbiota have been previously suggested to be tightly linked to
chronic systemic inflammation, which is a major contributing factor to complications and …

Chronic kidney diseases (CKDs) are a global health problem. Besides diverse leading
reasons in initiation and progression of CKDs, it is evident that they might largely originate …

Background Gut microbiota, particularly Oxalobacter formigenes, has been previously
reported to be associated with kidney stones. However, the conflicting results from both …

Background Therapeutic approaches that target the gut microbiota (GM) may be helpful in
the potential prevention and treatment of IgA nephropathy (IgAN). Meanwhile, relevant …

The present study aimed to determine the differences in gut microbiota between patients
with chronic kidney disease (CKD) and healthy controls (HC) and search for better microbial …

Background Emerging evidence demonstrates that gut dysbiosis is implicated in the
pathogenesis of chronic kidney disease (CKD) with underlying mechanisms involving …